scispace - formally typeset
W

W. Weyenberg

Researcher at University of Antwerp

Publications -  27
Citations -  867

W. Weyenberg is an academic researcher from University of Antwerp. The author has contributed to research in topics: PLGA & Zeta potential. The author has an hindex of 14, co-authored 27 publications receiving 799 citations.

Papers
More filters
Journal ArticleDOI

Mucoadhesive ocular insert based on thiolated poly(acrylic acid): development and in vivo evaluation in humans.

TL;DR: The in vivo study showed that ocular inserts based on thiolated poly(acrylic acid) are promising new solid devices for ocular drug delivery, whereas the fluorescein concentration rapidly decreased after application of aqueous eye drops or insertsbased on unmodified poly(Acrylic acid).
Journal ArticleDOI

PLGA nanoparticles and nanosuspensions with amphotericin B : potent **in vitro** and **in vivo** alternatives to Fungizone® and AmBisome®

TL;DR: It is demonstrated that the superior in vitro antifungal activity could be extrapolated to the in vivo situation and the developed AmB nanomedicines could represent potent and cost-effective alternatives to Fungizone and AmBisome.
Journal ArticleDOI

Cytotoxicity of submicron emulsions and solid lipid nanoparticles for dermal application

TL;DR: The cytotoxicity and physical properties of various submicron O/W emulsions and solid lipid nanoparticles for dermal applications were investigated and survival of macrophages was highly affected by stearic acid and stearylamine.
Journal ArticleDOI

Development and characterization of mucoadhesive chitosan films for ophthalmic delivery of cyclosporine A

TL;DR: None of the film formulations showed significant cytotoxicity as compared to the negative control using human epithelial cells (HaCaT).
Journal ArticleDOI

PLGA nanoparticles loaded with the antileishmanial saponin β-aescin: factor influence study and in vitro efficacy evaluation.

TL;DR: The in vitro results confirmed the hypothesis that poly(d,l-lactide-co-glycolide) nanoparticles (NPs) for the antileishmanial saponin β-aescin confirmed the therapeutic index of the conventional drugs in the treatment of visceral leishmaniasis.